Think global, act local! This is the Novartis business approach in India. A great believer in stakeholder collaboration, Jawed Zia, country president of Novartis India, explains how co-marketing deals with big names like Cipla and Lupin allow patients in every corner of the country to benefit from the company’s breakthrough products, standing out as a global healthcare innovator.
Novartis underwent a major restructuring in 2016, splitting its pharmaceutical division into two business units, one focused on oncology and the other on the remaining therapeutic areas. How does this translate in the Indian context?
"In a country like India where the vast majority of people live in rural areas and where millions live on less than USD 2 a day, a great share of the responsibility to provide them with healthcare lies with the government."
